lobbying_activities: 1584022

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1584022	eb9f9e19-1dd6-460c-84e3-f18c1429b6bd	Q3	PARRY, ROMANI, DECONCINI & SYMMS	30792	POZEN, INC.	2014	third_quarter	PHA	Support H.R.2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.	HOUSE OF REPRESENTATIVES,SENATE	36000		0	0	2014-10-10T14:38:20.850000-04:00